Management of hepatitis C virus infection in the Asia-Pacific region: an update
- 1 January 2017
- journal article
- review article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 2 (1) , 52-62
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyHIV Medicine, 2012
- The interaction of metabolic factors with HCV infection: Does it matter?Journal of Hepatology, 2012
- Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/Hepatitis C Virus Patients Receiving Pegylated-Interferon and RibavirinJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and EgyptLiver International, 2011
- Performance of the Aspartate Aminotransferase-to-Platelet Ratio Index for the Staging of Hepatitis C-Related Fibrosis: An Updated Meta-Analysis §ΔHepatology, 2010
- Antiviral therapy in HCV-infected decompensated cirrhoticsSaudi Journal of Gastroenterology, 2010
- The impact of hepatic steatosis on the natural history of chronic hepatitis C infectionJournal of Viral Hepatitis, 2009
- Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitisJournal of Viral Hepatitis, 2009
- Health-Care Systems and Pharmacoeconomic Research in Asia-Pacific RegionValue in Health, 2008
- Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtypeHepatology Research, 2007